222 related articles for article (PubMed ID: 31330366)
1. Molecular pathogenesis of gallbladder cancer: An update.
Mishra SK; Kumari N; Krishnani N
Mutat Res; 2019 Nov; 816-818():111674. PubMed ID: 31330366
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA aberrations: An emerging field for gallbladder cancer management.
Chandra V; Kim JJ; Mittal B; Rai R
World J Gastroenterol; 2016 Feb; 22(5):1787-99. PubMed ID: 26855538
[TBL] [Abstract][Full Text] [Related]
3. The emerging role of long non-coding RNA in gallbladder cancer pathogenesis.
Khandelwal A; Malhotra A; Jain M; Vasquez KM; Jain A
Biochimie; 2017 Jan; 132():152-160. PubMed ID: 27894946
[TBL] [Abstract][Full Text] [Related]
4. Decoding the role of long non-coding RNAs in gallbladder cancer pathogenesis: A review focus on signaling pathways interplay.
Doghish AS; Radwan AF; Zaki MB; Elfar N; Moussa R; Walash Z; Alhamshry NAA; Mohammed OA; Abdel-Reheim MA; Elimam H
Int J Biol Macromol; 2024 Apr; 264(Pt 1):130426. PubMed ID: 38428766
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathways and potential biomarkers in gallbladder cancer: A comprehensive review.
Montalvo-Jave EE; Rahnemai-Azar AA; Papaconstantinou D; Deloiza ME; Tsilimigras DI; Moris D; Mendoza-Barrera GE; Weber SM; Pawlik TM
Surg Oncol; 2019 Dec; 31():83-89. PubMed ID: 31541911
[TBL] [Abstract][Full Text] [Related]
6. In silico analysis unveiling potential biomarkers in gallbladder carcinogenesis.
Gupta RK; Bhushan R; Kumar S; Prasad SB
Sci Rep; 2024 Jun; 14(1):14570. PubMed ID: 38914609
[TBL] [Abstract][Full Text] [Related]
7. A systematic review with in silico analysis on transcriptomic profile of gallbladder carcinoma.
Tulsyan S; Hussain S; Mittal B; Saluja SS; Tanwar P; Rath GK; Goodman M; Kaur T; Mehrotra R
Semin Oncol; 2020 Dec; 47(6):398-408. PubMed ID: 33162112
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of hsa‑miR‑372 predicts poor prognosis in patients with gallbladder cancer by affecting chloride intracellular channel 1.
Zhou N; Cheng W; Peng C; Liu Y; Jiang B
Mol Med Rep; 2017 Nov; 16(5):7848-7854. PubMed ID: 28944858
[TBL] [Abstract][Full Text] [Related]
9. The emerging roles of long non-coding RNA in gallbladder cancer tumorigenesis.
Chen B; Li Y; He Y; Xue C; Xu F
Cancer Biomark; 2018; 22(3):359-366. PubMed ID: 29758925
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress and deregulations in base excision repair pathway as contributors to gallbladder anomalies and carcinoma - a study involving North-East Indian population.
Singh N; Kazim SN; Sultana R; Tiwari D; Borkotoky R; Kakati S; Nath Das N; Kumar Saikia A; Bose S
Free Radic Res; 2019 May; 53(5):473-485. PubMed ID: 31117842
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic profiling of gallbladder cancer and gall stone diseases: Evaluation of role of tumour associated genes.
Singh TD; Gupta S; Shrivastav BR; Tiwari PK
Gene; 2016 Feb; 576(2 Pt 2):743-52. PubMed ID: 26456195
[TBL] [Abstract][Full Text] [Related]
12. Novel biomarkers for the diagnosis and prognosis of gallbladder cancer.
Lin HZ; Zhang T; Chen MY; Shen JL
J Dig Dis; 2021 Feb; 22(2):62-71. PubMed ID: 33369216
[TBL] [Abstract][Full Text] [Related]
13. Epigenome-Wide Analysis of Methylation Changes in the Sequence of Gallstone Disease, Dysplasia, and Gallbladder Cancer.
Brägelmann J; Barahona Ponce C; Marcelain K; Roessler S; Goeppert B; Gallegos I; Colombo A; Sanhueza V; Morales E; Rivera MT; de Toro G; Ortega A; Müller B; Gabler F; Scherer D; Waldenberger M; Reischl E; Boekstegers F; Garate-Calderon V; Umu SU; Rounge TB; Popanda O; Lorenzo Bermejo J
Hepatology; 2021 Jun; 73(6):2293-2310. PubMed ID: 33020926
[TBL] [Abstract][Full Text] [Related]
14. Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer.
Alvarez H; Corvalan A; Roa JC; Argani P; Murillo F; Edwards J; Beaty R; Feldmann G; Hong SM; Mullendore M; Roa I; Ibañez L; Pimentel F; Diaz A; Riggins GJ; Maitra A
Clin Cancer Res; 2008 May; 14(9):2631-8. PubMed ID: 18451226
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation as an epigenetic regulator of gallbladder cancer: An overview.
Muhammad JS; Khan MR; Ghias K
Int J Surg; 2018 May; 53():178-183. PubMed ID: 29602013
[TBL] [Abstract][Full Text] [Related]
16. Genomics of gallbladder cancer: the case for biomarker-driven clinical trial design.
Sicklick JK; Fanta PT; Shimabukuro K; Kurzrock R
Cancer Metastasis Rev; 2016 Jun; 35(2):263-75. PubMed ID: 26857926
[TBL] [Abstract][Full Text] [Related]
17. The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR.
Zhao S; Cao Y; Liu SB; Wang XA; Bao RF; Shu YJ; Hu YP; Zhang YJ; Jiang L; Zhang F; Liang HB; Li HF; Ma Q; Xu Y; Wang Z; Zhang YC; Chen L; Zhou J; Liu YB
J Exp Clin Cancer Res; 2016 Jun; 35(1):97. PubMed ID: 27317099
[TBL] [Abstract][Full Text] [Related]
18. miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma.
Bao RF; Shu YJ; Hu YP; Wang XA; Zhang F; Liang HB; Ye YY; Li HF; Xiang SS; Weng H; Cao Y; Wu XS; Li ML; Wu WG; Zhang YJ; Jiang L; Dong Q; Liu YB
Oncotarget; 2016 Apr; 7(16):22339-54. PubMed ID: 26968949
[TBL] [Abstract][Full Text] [Related]
19. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.
Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB
Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055
[TBL] [Abstract][Full Text] [Related]
20. miRNAs orchestration of gallbladder cancer - Particular emphasis on diagnosis, progression and drug resistance.
Shahin RK; Elkady MA; Abulsoud AI; Abdelmaksoud NM; Abdel Mageed SS; El-Dakroury WA; Zewail MB; Elazazy M; Sobhy MH; Nomier Y; Elazazy O; Elballal MS; Mohammed OA; Midan HM; Elrebehy MA; Ziada BO; Doghish AS
Pathol Res Pract; 2023 Aug; 248():154684. PubMed ID: 37454489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
